BACKGROUND: Invasive dental treatments (IDTs) can yield temporary bacteremia and have therefore been considered a potential risk factor of infective endocarditis (IE). It is hypothesized that, through the trauma caused by IDTs, bacteria gain entry to the bloodstream and may attach to abnormal heart valves or damaged heart tissue, giving rise to IE. However, the association between IDTs and IE remains controversial. The aim of this study is to estimate the association between IDTs and IE.
I
nfective endocarditis (IE) is a rare but life-threatening disease. IE is an infection of the endocardial surface of the heart, which may involve ≥1 heart valves. If patients with IE do not receive appropriate treatment, they may develop serious complications or die. The annual incidence of IE is ≈3 to 9 cases per 100 000 persons in industrialized countries, with the mean age varying between 36 and 69 years, and the incidence is higher in men than in women. 1, 2 Mitral valve prolapse, congenital heart disease, rheumatic heart disease, previous IE, and previous cardiac valve surgery are risk factors for IE. 3 Invasive dental treatments (IDTs) have been considered a potential risk factor of IE; however, the association between IDTs and IE remains controversial. Dental treatments were considered IDTs when the treatments might cause bleeding and introduce oral bacteria into the bloodstream, such as dental cleaning, scaling and root planing, extraction, odontectomy, and periodontal surgery. IDTs can yield temporary bacteremia that may attach to abnormal heart valves or damaged heart tissue, giving rise to IE. The association between IDTs and IE has been observed in many studies, [4] [5] [6] [7] whereas others show no association between IDTs and a larger risk of IE, or the risk is small. [8] [9] [10] [11] [12] [13] [14] Nevertheless, it has been suggested that issues such as sample size, study target population selection, and confounding may contribute to the uncertainty surrounding the relation between IDTs and IE. It is notable that the current guidelines for IE have been revised through time, 15 with the American Heart Association, the French consensus conference, and the European Society of Cardiology previously recommending prophylaxis broadly, but more recently only for patients with a high risk of IE, such as those with a history of IE, cardiac valve replacement, prosthetic valves, cyanotic congenital heart disease, etc. 3, 16, 17 The UK National Institute for Health and Care Excellence no longer recommends routine antibiotic prophylaxis against IE. 18 A carefully designed large study, with an adequate number of patients, is therefore required to help resolve this controversial issue, especially for patients with a high risk of IE. 19 We conducted a nationwide case-only study, based on within-person comparisons, by using a large national cohort in Taiwan. The advantage is that confounding factors that do not vary with time are adjusted for implicitly. The aim of this study is to investigate the association between IDTs and IE. We first estimated if IDTs were associated with a larger risk for IE in the short period following IDTs. We then investigated the risk of IE among high-risk patients, such as patients with rheumatic heart disease and valve replacement. We also evaluated the relation of antibiotic prophylaxis to the prevention of IE.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Health Insurance Database
The data in this study were obtained from the Health Insurance Database in Taiwan. The National Health Insurance program in Taiwan was launched on March 1, 1995, with 99.9% of Taiwan's population enrolled in the program by 2014. 20 All registrations and claim data of participants were available to this study, including date of birth; sex; dates of clinical visits; the International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes; prescriptions; details of surgery; and expenditure of all treatments. Moreover, the Health Insurance Database could be linked to the database of Cause of Death in the Ministry of Internal Affairs to obtain the information date and main cause of death. All participants were followed from 2002 to 2013, or the date of loss to follow-up (dropout from the insurance program, including death). The current study has been approved by the ethics committee of National Taiwan University Hospital (NO.201504015 W). Consent from participants was waived because the data in the cohort have all been anonymized.
Clinical Perspective
What Is New?
• Invasive dental treatments did not appear to be associated with a larger risk for infective endocarditis in the short period following invasive dental treatments in the Taiwanese population, with consistent findings obtained from both study designs, namely case-crossover design and self-controlled case series design.
• We also did not find any association between invasive dental treatments and infective endocarditis among patients with a high risk for infective endocarditis, such as those with a history of rheumatic heart disease or valve replacement.
What Are the Clinical Implications?
• Antibiotic prophylaxis has been recommended for the prevention of infective endocarditis in patients with a high risk for infective endocarditis.
• However, the effectiveness of antibiotic prophylaxis has remained a controversial issue for decades.
• Our large population-based study did not observe any clinically significant association between invasive dental treatments and a larger risk of infective endocarditis.
• We found no evidence to support antibiotic prophylaxis for the prevention of infective endocarditis before invasive dental treatments in the Taiwanese population, and whether antibiotic prophylaxis is necessary in other populations requires further evidence.
ORIGINAL RESEARCH ARTICLE

Study Population
We included all patients with IE between 
Exposure: IDTs
IDTs in this study included the following treatments: dental cleaning, scaling and root planing, simple extraction, complicated extraction, odontectomy in both simple case and complicated case, and periodontal surgery. The definition of IDTs was the same in both study designs, and the procedure codes for IDTs are shown in Table I in the online-only Data Supplement.
Study Design
We selected 2 case-only study designs, according to the characteristics of IDTs and IE: case-crossover and self-controlled case series. It is challenging to investigate the association between IDTs and IE because IDTs are so widespread; hence, it is hard to identify an appropriate dental control group. IDTs are also likely to be intermittent, dynamic, and transient. In addition, the power of statistical analysis may often be insufficient because IE is a rare and acute event. Therefore, we use case-only study designs to undertake within-subject comparisons. These study designs are suitable for investigating the relationship of intermittent exposure with transient effects on acute and rare events. The advantage of these methods is that confounding factors that do not vary with time are adjusted for implicitly.
Case-Crossover Design
Case-crossover design is a special type of case-only study, 21, 22 where patients serve as their own control. This avoids selection bias in the control group, including healthy volunteer bias and confounder bias (eg, caused by sex and socioeconomic position) that is automatically controlled for. In the case-crossover design, the exposure, ie, receiving IDTs, was measured during the exposure period in both case and control, respectively. The exposure period is a period before and up to the index date (ie, with the exclusion of the index date), where the index date is defined as the date of IE onset. The index date for controls was defined as 6 months before the onset of IE. We considered the length of exposure period to be either 4, 8, 12, or 16 weeks before the index date for both cases and controls. Figure I in the online-only Data Supplement shows the diagram of the observation period for the first 3 patients in the case-crossover design.
Self-Controlled Case Series Design
Self-controlled case series is also a special design of a caseonly study, again based on within-person comparisons. [23] [24] [25] [26] Each patient was followed from January 1, 2004, or from the date of becoming 20 years old, depending on which is the later, to December 31, 2013, or the date of loss to follow-up (ie, dropout from the insurance program, including death), depending on which is the former. We assume that the risk of IE would have returned to baseline by 16 weeks after IDTs, and that risk during the weeks 1 to 4, 5 to 8, 9 to 12, and 13 to 16 were all different and therefore estimated separately; the remaining period was taken as the baseline period. We adjusted for patients' age under observation periods to minimize confounding bias, and we show more details in the online-only Data Supplement and an example in Figure II in the online-only Data Supplement. Figure III in the online-only Data Supplement shows a diagram of the observation period for the first 3 patients in the self-controlled case series design. Patients without IDTs during the observation period were excluded. The advantage of this method is that confounding factors that do not vary with time, such as sex and socioeconomic position, are adjusted for implicitly. We only used the first IE event and did several sensitivity analyses for the robustness of the self-controlled case series design. Subsequent IE events were excluded, because a patient might experience multiple IE events that might not be independent. 26 Because experiencing an IE may increase the probability of death, we did a sensitivity analysis in which patients who died within 30 days of IE were excluded. 27 IE may also decrease the probability of patients receiving IDTs for a period of time until they fully recovered. The risk of IE events is therefore particularly low in the short period before IDTs. If we include this short period in the baseline period, we may underestimate the baseline risk of IE and hence overestimate the relative incidence of risk periods after IDTs. To address this issue, we did sensitivity analysis in which 1 week or 1 to 4 weeks before IDTs were excluded from the baseline period and were considered the preexposure risk period instead.
26
Covariates
Data from the claim database on potential confounding were obtained for patients' age, sex, and comorbid conditions. We identified comorbidities with International Classification of Diseases, Ninth Revision, Clinical Modification codes if they had been used ≥1 times in the diagnoses of inpatients or ≥3 times in the diagnoses of outpatients within 6 months before the index date. In addition, cardiac valve replacement was defined as receiving surgery of valve replacement within 6 months before the index date. The detailed information for diagnoses of comorbidities and surgery of valve replacement can be found Tables II and III in the online-only Data Supplement, respectively.
Statistical Analysis
The conditional logistic regression model and the conditional Poisson regression model were used for case-crossover design and self-controlled case series design, respectively. The conditioning was based on the number of IE events in each patient; this yields within-person comparisons, such that individual effects cancel out and need not be estimated. We also looked into the interaction between IDTs and sex in both designs.
All analyses were performed by using the statistical software packages SAS (SAS System for Windows, Version 9.4) and STATA (version14). We used SAS macro code and STATA 
RESULTS
The study target Taiwan population was ≈23 million, and the number of births was ≈200 000 each year. The cumulative number of subjects enrolled in the Health Insurance program was ≈27 million up to 2013. We identified 16 315 patients with IE between 2002 and 2013.
Case-Crossover Design
Figure IV in the online-only Data Supplement shows the flow diagram for case-crossover design. We excluded patients with events occurring before 2005, with missing age or sex, or with ages <20 or >100 years, yielding 9120 patients with IE in the case-crossover design.
The characteristics of these patients with IE are shown in Table 1 . Most patients diagnosed with IE were >40 years of age, and there were more men than women. IE occurred more often in the summer (June to August) than in other seasons. There were 5.0% and 3.2% of patients with a history of rheumatic heart disease for cases and controls, respectively; and <1% patients received valve replacement surgery in both cases and controls. The odds ratios (ORs) of IE ( Figure 1) 
Self-Controlled Case Series Design
Figure V in the online-only Data Supplement shows the flow diagram for self-controlled case series design. After excluding patients aged <20 or >100 years, with events before 2004, with no events during the observation period, or with missing sex or age, 8181 patients with IE remained for the self-controlled case series study. Baseline characteristics are shown in Table 2 : most patients were diagnosed with IE when they were >40 years of age, and there were more men than women. Approximately 4.6% of patients also had rheumatic heart disease, and 3.9% of patients received cardiac valve replacement within 6 months before their first IDT event.
With the use of 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs as separate risk periods of IE and the remaining time period as the baseline, the age-adjusted incidence rate ratios in Figure 2 were 1.14 (95% CI, 1.02-1.26), 1.08 (95% CI, 0.96-1.21), 1.06 (95% CI, 0.94-1.19), and 1.12 (95% CI, 0.99-1.26), respectively. The interaction between IDTs and sex was not statistically significant and therefore was excluded in the final model. For men, the age-adjusted incidence rate ratios were 1.15 (95% CI, 1.01-1.31), 1.07 (95% CI, 0.93-1.23), 1.00 (95% CI, 0.85-1.16), and 1.21 (95% CI, 1.05-1.40) during 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs, respectively. For women, the age-adjusted incidence rate ratios were 1.12 (95% CI, 0.94-1.33), 1.10 (95% CI, 0.91-1.33), 1.17 (95% CI, 0.97-1.41), and Figure VI in the online-only Data Supplement. The age-adjusted incidence rate ratios among patients with rheumatic heart disease were 1.01 (95% CI, 0.60-1.68), 1.10 (95% CI, 0.65-1.86), 0.97 (95% CI, 0.54-1.74), and 0.78 (95% CI, 0.40-1.53) during 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs, respectively. The age-adjusted incidence rate ratios among patients with valve replacement were 0.47 (95% CI, 0.21-1.07), 0.73 (95% CI, 0.36-1.50), 0.31 (95% CI, 0.10-0.96), and 0.66 (95% CI, 0.29-1.51) during 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs, respectively.
To investigate the effect of antibiotic prophylaxis, we estimated separate risks of IE after IDTs for patients with or without antibiotic prophylaxis when they received IDTs. The age-adjusted incidence rate ratios for IDTs without antibiotic prophylaxis were 1.16 (95% CI, 1.03-1.31), 1.07 (95% CI, 0.94-1.22), 1.02 (95% CI, 0.88-1.17), and 1.09 (95% CI, 0.95-1.26) during 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs, respectively. For IDTs with antibiotic prophylaxis, the age-adjusted incidence rate ratios were 1.07 (95% CI, 0.88-1.30), 1.11 (95% CI, 0.90-1.38), 1.18 (95% CI, 0.95-1.47), and 1.19 (95% CI, 0.95-1.50) during 1 to 4, 5 to 8, 9 to 12, and 13 to 16 weeks after IDTs, respectively. 
DISCUSSION
Main Findings
In this large Taiwanese cohort, we did not observe an association between IDTs and a larger risk for IE in the short period following IDTs. We also did not find an association between IDTs and IE among patients with a high risk of IE, such as those with rheumatic heart disease or valve replacement. Antibiotic prophylaxis did not seem to provide any substantial benefit on the prevention of IE. Our findings do not support the hypothesis that patients receiving IDTs have a higher risk of IE.
Comparison With Previous Studies
Previously, 3 small case-control studies did not find an association between IDTs and a larger risk for IE. [8] [9] [10] Two were case-crossover studies: 1 with only 170 hospitalized patients with IE 9 and the other with 713 patients with IE. 8 The later study analyzed a randomly selected sample of National Health Insurance Research Database in Taiwan. Because its number of IE cases was limited, the statistical power would be low to estimate a small or moderate association with IDTs with any degree of confidence. Furthermore, the number of cases with valvular heart disease was even smaller, so it would not be feasible to investigate the association between IDTs and IE among patients with a high risk of IE. In contrast, we used data from the whole Taiwanese population, so we identified 20 times more IE cases with sufficient numbers of patients with previous rheumatic heart disease or valve replacement. The small risk estimates in our population-wide study examining the relationship between IDTs and IE suggest that the association between IDTs and IE is clinically insignificant. Odds ratios of invasive dental treatments and infective endocarditis with control were selected from 6 months before the onset of infective endocarditis in the case-crossover design. For the concordant and discordant pairs, the first and second entries indicate whether a patient received invasive dental treatments in the case or control within an exposure period, respectively. C.I. indicates confidence interval; N, no; and Y, yes, namely receiving invasive dental treatment.
Circulation. 
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Some studies found an association between IDTs and IE, but the design of these studies was often inadequate. For instance, a comparable control group was not included and confounding bias was not properly adjusted for. A case-control study showed that cases were more likely than controls to have undergone IDTs during the previous 3 months, with an OR of 3.31 (95% CI, 1.18-9.29). 4 However, information about dental hygiene and oral health status was collected after the IE onset. This may lead to reverse causation, because proper oral hygiene and dental treatments may be less attainable in patients with IE. In our study, oral hygiene was implicitly controlled for, because we used the self-controlled design. A recent study used both cohort and case-crossover design to investigate the association between IDTs and IE among patients with prosthetic heart valves. 29 The cohort included 138 876 patients with prosthetic heart valves and 648 patients with both prosthetic heart valves and IE for the casecrossover study. The results showed that IDTs may be associated with a greater risk of IE with an OR of 1.66 (95% CI, 1.05-2.63) in the case-crossover study design, but the association between IDTs and IE was not statistically significant in the cohort study design. In contrast, our 2 study designs consistently found no association between IDTs and a larger risk for IE.
Antibiotic prophylaxis has been recommended for the prevention of IE in patients with a high risk of IE. However, the effectiveness of antibiotic prophylaxis has remained a controversial issue for decades. In a previous study, Duval et al 30 used population data in France to show that the risks of developing IE were 1 in 46 000 and 1 in 150 000 for dental procedures without and with antibiotic prophylaxis, respectively. According to their results, the number needed to treat is therefore ≈66 346 patients 31 ; that is, 66 346 patients would have had to be given antibiotic prophylaxis to prevent a case of IE. Because our study only included patients with IE for both designs, we are therefore unable to calculate the number needed to treat for the efficacy of antibiotic prophylaxis. Because our large population-based study did not observe any clinically significant association between IDTs and a larger risk of IE, it is questionable that antibiotic prophylaxis before IDTs is required for the prevention of IE in the Taiwanese population. Our findings also cast doubt on the necessity of antibiotic prophylaxis in other populations.
Strength and Weakness
The main strength of this study is the large sample size, which is much greater than any previous study. Because the incidence of IE is rare, the use of the whole population database in Taiwan minimizes the chance of falsenegative findings. Another strength is that 2 case-only designs were used to overcome the difficulty in identifying appropriate control groups, and their results were consistent.
We also did several sensitivity analyses to evaluate the robustness of our study designs by excluding patients who died within 30 days of IE and by excluding the short period of time before IDT from the baseline period. Both sensitivity analyses found no substantial difference in the results from those of the main analysis, thereby indicating that our observation of no association between IDTs and a larger risk of IE is robust.
We also investigated the issue of antibiotic prophylaxis in the prevention of IE. Because the age-adjusted incidence rate ratios were very similar between patients with and without antibiotic prophylaxis, it does not seem to provide any substantial benefit. 
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Limitations of this study include the identification of cases of IE through the International Classification of Diseases, Ninth Revision, Clinical Modification codes in the medical claims, so we have no information about how the diagnosis of IE was made. For instance, it is unclear whether blood cultures and heart ultrasound were undertaken, although we excluded outpatients from our analysis to minimize the potential misclassification bias. Furthermore, among the patients with IE, only 376 and 317 had rheumatic heart disease or cardiac valve replacement, respectively, despite the fact that we had access to the whole population of Taiwan. Therefore, we were not able to evaluate the influence of antibiotic prophylaxis on the prevention of IE among patients with rheumatic heart disease or cardiac valve replacement. Finally, although we have medical prescription records in our database, we cannot know the exact use of medicines. If patients received antibiotic prophylaxis but the dentist chose not to make a claim for the cost of antibiotics, the patient is considered a nonuser, thus adding to the risk of misclassification bias. This may result in the underestimation of the risk for IE after IDTs without antibiotic prophylaxis and consequently underestimate the effect of antibiotic prophylaxis on the prevention of IE. This issue can only be resolved if the full medical records are made available.
In conclusion, IDTs did not appear to be associated with a larger risk for IE in the short period following IDTs in the Taiwanese population, with consistent findings obtained from both study designs. We also did not find any association between IDTs and IE among patients with a high risk of IE, such as those with a history of rheumatic heart disease or valve replacement. Because antibiotic prophylaxis has been recommended for the prevention of IE in patients with a high risk of IE, our results suggest that these recommendations should be reassessed considering new evidence of the potential risk of adverse drug reactions to antibiotic prophylaxis. 32 The association between IDTs and IE may have been overstated previously, and a more practical approach to the dental treatment of patients with high risk of IE should now be considered. Figure 2 . Association of invasive dental treatments with infective endocarditis in all patients and in different sexes from selfcontrolled case series design. Age-adjusted incidence rate ratios of infective endocarditis after invasive dental treatments in the self-controlled case series design. C.I. indicates confidence interval; IDT, invasive dental treatment; and IE, infective endocarditis.
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